Mularoni, Cecilia
Servillo, Andrea
Sacconi, Riccardo http://orcid.org/0000-0003-2891-2012
Battista, Marco http://orcid.org/0000-0001-5940-6177
Crincoli, Emanuele
Crepaldi, Anna
Querques, Lea
Bandello, Francesco http://orcid.org/0000-0003-3238-9682
Querques, Giuseppe http://orcid.org/0000-0002-3292-9581
Article History
Received: 7 May 2023
Revised: 18 September 2023
Accepted: 25 September 2023
First Online: 9 October 2023
Competing interests
: RS is consultant for Allergan Inc, Bayer Shering-Pharma, Medivis, Novartis, and Zeiss. FB is consultant for Alcon, Alimera Sciences, Allergan Inc, Farmila-Thea, Bayer Shering-Pharma, Baush and Lomb, Genentech, Hoffmann-La-Roche, Novagali Pharma, Novartis, Sanofi-Aventis, Thrombogenics, and Zeiss. GQ is consultant for Alimera Sciences, Allergan Inc, Amgen, Bayer Shering-Pharma, Heidelberg, KBH, LEH Pharma, Lumithera, Novartis, Sandoz, Sifi, Sooft-Fidea, and Zeiss. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.